Mediterranean diet and the Spanish paradox. A hypothesis.

[1]  Mark D. Huffman,et al.  Novel treatments for cardiovascular disease prevention. , 2012, Cardiovascular therapeutics.

[2]  E. García‐Fuentes,et al.  Children whose diet contained olive oil had a lower likelihood of increasing their body mass index Z-score over 1 year. , 2011, European journal of endocrinology.

[3]  U. Risérus,et al.  Role of hepatic desaturases in obesity-related metabolic disorders , 2010, Current opinion in clinical nutrition and metabolic care.

[4]  D. Mutch,et al.  Genetic variation in lipid desaturases and its impact on the development of human disease , 2010, Lipids in Health and Disease.

[5]  T. Kott,et al.  The polymorphisms of stearoyl-CoA desaturase (SCD1) and sterol regulatory element binding protein-1 (SREBP-1) genes and their association with the fatty acid profile of muscle and subcutaneous fat in Fleckvieh bulls. , 2010, Meat science.

[6]  J. A. Menéndez,et al.  Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  F. Soriguer,et al.  Nutritional regulation of interleukin-6 release from adipocytes , 2010, International Journal of Obesity.

[8]  Salim Yusuf,et al.  Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. , 2010, European heart journal.

[9]  J. Madenspacher,et al.  Combined Therapy of Dietary Fish Oil and Stearoyl-CoA Desaturase 1 Inhibition Prevents the Metabolic Syndrome and Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Fessler,et al.  Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome , 2009, Current opinion in lipidology.

[11]  F. Soriguer,et al.  Intake and home use of olive oil or mixed oils in relation to healthy lifestyles in a Mediterranean population. Findings from the prospective Pizarra study , 2009, British Journal of Nutrition.

[12]  J. V. Vanden Heuvel,et al.  Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: Implications for the dietary management of elevated serum triglycerides. , 2009, Journal of clinical lipidology.

[13]  H. Blackburn,et al.  Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. , 2009, Acta medica Scandinavica. Supplementum.

[14]  Jun Yu,et al.  Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice , 2009, Scandinavian journal of gastroenterology.

[15]  B. Vessby,et al.  Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  Heather M. Alger,et al.  Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis , 2008, Circulation.

[17]  Zhihua Jiang,et al.  Significant associations of stearoyl-CoA desaturase (SCD1) gene with fat deposition and composition in skeletal muscle , 2008, International journal of biological sciences.

[18]  J. Ntambi,et al.  Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism , 2008, Current opinion in lipidology.

[19]  K. Kristiansen,et al.  cAMP-dependent Signaling Regulates the Adipogenic Effect of n-6 Polyunsaturated Fatty Acids* , 2008, Journal of Biological Chemistry.

[20]  T. A. Richardson,et al.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. , 2008, Cell metabolism.

[21]  F. Pavón,et al.  The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats , 2008, Neuropharmacology.

[22]  F. Soriguer,et al.  Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil. , 2007, Molecular nutrition & food research.

[23]  E. Ingelsson,et al.  Polymorphisms in the SCD1 Gene: Associations With Body Fat Distribution and Insulin Sensitivity , 2007, Obesity.

[24]  Harini Sampath,et al.  Stearoyl-CoA Desaturase-1 Mediates the Pro-lipogenic Effects of Dietary Saturated Fat* , 2007, Journal of Biological Chemistry.

[25]  P Mata,et al.  International conference on the healthy effect of virgin olive oil , 2005, European journal of clinical investigation.

[26]  Danielle G. Lemay,et al.  Saturated and Polyunsaturated Fatty Acids Reciprocally Modulate Dendritic Cell Functions Mediated through TLR41 , 2005, The Journal of Immunology.

[27]  A. Dobrzyń,et al.  Stearoyl‐CoA desaturase as a new drug target for obesity treatment , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[28]  M. J. Medrano,et al.  Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales , 2005 .

[29]  J. Friedman,et al.  Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. , 2005, American journal of physiology. Endocrinology and metabolism.

[30]  M. Miyazaki,et al.  Regulation of stearoyl-CoA desaturase expression , 2004, Lipids.

[31]  M. Miyazaki,et al.  Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400039-JLR200 , 2004, Journal of Lipid Research.

[32]  H. Sampath,et al.  Polyunsaturated fatty acid regulation of gene expression. , 2004, Journal of molecular neuroscience : MN.

[33]  M. Miyazaki,et al.  Reduced Adiposity and Liver Steatosis by Stearoyl-CoA Desaturase Deficiency Are Independent of Peroxisome Proliferator-activated Receptor-α* , 2004, Journal of Biological Chemistry.

[34]  R. Rodrigo,et al.  Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. , 2004, Clinical science.

[35]  J. Friedman,et al.  Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Bellenger,et al.  A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  P. Guesnet,et al.  Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[38]  F. Tinahones,et al.  Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats , 2003, British Journal of Nutrition.

[39]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[40]  M. Miyazaki,et al.  Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[42]  D. Pella,et al.  Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.

[43]  A. Brownlie,et al.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200189-JLR200 , 2002, Journal of Lipid Research.

[44]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Socci,et al.  Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss , 2002, Science.

[46]  M. Miyazaki,et al.  Oleoyl-CoA Is the Major de Novo Product of Stearoyl-CoA Desaturase 1 Gene Isoform and Substrate for the Biosynthesis of the Harderian Gland 1-Alkyl-2,3-diacylglycerol* , 2001, The Journal of Biological Chemistry.

[47]  Y. C. Kim,et al.  A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. , 2001, Journal of lipid research.

[48]  Robert V Farese,et al.  Mammalian acyl-CoA:cholesterol acyltransferases. , 2000, Biochimica et biophysica acta.

[49]  M. Miyazaki,et al.  The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1* , 2000, The Journal of Biological Chemistry.

[50]  F. Tinahones,et al.  Varying incorporation of fatty acids into phospholipids from muscle, adipose and pancreatic exocrine tissues and thymocytes in adult rats fed with diets rich in different fatty acids , 2000, European Journal of Epidemiology.

[51]  M. Prentki,et al.  Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. , 1999, Diabetes.

[52]  J. Ntambi.  Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. , 1999, Journal of lipid research.

[53]  J. Marrugat,et al.  High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. , 1998, Journal of epidemiology and community health.

[54]  Banegas Banegas,et al.  [Cardiovascular mortality in Spain and its autonomous communities (1975-1992)]. , 1998 .

[55]  R. Tresserras,et al.  How could changes in diet explain changes in coronary heart disease mortality in Spain? The Spanish paradox. , 1995, The American journal of clinical nutrition.

[56]  W. Willett,et al.  Mediterranean diet pyramid: a cultural model for healthy eating. , 1995, The American journal of clinical nutrition.

[57]  P. Touboul,et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[58]  G. Vassaux,et al.  Prostacyclin is a specific effector of adipose cell differentiation. Its dual role as a cAMP- and Ca(2+)-elevating agent. , 1992, The Journal of biological chemistry.

[59]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[60]  A. Keys,et al.  X. Rural Southern Japan , 1970 .

[61]  A. Keys,et al.  Coronary heart disease in seven countries. X. Rural southern Japan. , 1970, Circulation.

[62]  E. Simonson,et al.  Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years , 1963, Circulation.

[63]  G. Burr,et al.  ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION , 1930 .

[64]  E. García‐Fuentes,et al.  Title: Children whose diet contained olive oil had a lower likelihood of increasing their BMI Z-score over one year. , 2011 .

[65]  M. Delgado-Rodríguez,et al.  [Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies]. , 2005, Medicina clinica.

[66]  F. Villar Álvarez,et al.  [Cardiovascular mortality in Spain and its autonomous communities (1975-1992)]. , 1998, Medicina clínica (Ed. impresa).

[67]  J. Ntambi,et al.  The regulation of stearoyl-CoA desaturase (SCD). , 1995, Progress in lipid research.

[68]  A. A. Spector,et al.  Essential fatty acid availability and prostacyclin production by cultured human endothelial cells. , 1981, Progress in lipid research.